logo

For the Inventor, By the Inventor

Pleasant Hill, CA, United States of America

Thomas K Tcheng

USPTO Granted Patents = 47 



Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 1,316(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (2006 - 2007)
  • Pleasant Hill, CA (US) (2004 - 2024)

Company Filing History:

goldMedal44 out of 201 
 
Neuropace, Inc.
 patents
silverMedal3 out of 832,718 
Other
 patents

Years Active: 2004-2025

Loading Chart...
Loading Chart...
Loading Chart...
47 patents (USPTO):Explore Patents
1. 12333443 - Systems and methods for using federated learning for training centralized seizure detection and prediction models on decentralized datasets (2025-06-17),
2. 12138064 - Systems, devices and methods using phase-amplitude coupling measures in implantable medical devices (2024-11-12),
3. 12029581 - Systems and methods for assessing the effectiveness of a therapy including a drug regimen using an implantable medical device (2024-07-09),
4. 11842255 - Systems and methods for labeling large datasets of physiological records based on unsupervised machine learning (2023-12-12),
5. 11771898 - Seizure onset classification and stimulation parameter selection (2023-10-03),
6. 11690553 - Multimodal brain sensing lead (2023-07-04),
7. 11481578 - Systems and methods for labeling large datasets of physiological records based on unsupervised machine learning (2022-10-25),
8. 11478642 - Seizure onset classification and stimulation parameter selection (2022-10-25),
9. 11439826 - Systems and methods for clinical decision making for a patient receiving a neuromodulation therapy based on deep learning (2022-09-13),
10. 11406824 - Systems, methods and devices for a skull/brain interface (2022-08-09),
11. 11064926 - Systems and methods for assessing the effectiveness of a therapy including a drug regimen using an implantable medical device (2021-07-20),
12. 11026617 - Multimodal brain sensing lead (2021-06-08),
13. 10966625 - Systems, devices and methods using phase-amplitude coupling measures in implantable medical devices (2021-04-06),
14. 10729907 - Systems and methods for clinical decision making for a patient receiving a neuromodulation therapy based on deep learning (2020-08-04),
15. 10543368 - Seizure onset classification and stimulation parameter selection (2020-01-28),

Title: Innovations in Medical Technology: The Contributions of Thomas K. Tcheng

Introduction

Thomas K. Tcheng, based in Pleasant Hill, California, has made significant strides in the field of medical technology. With an impressive portfolio of 43 patents, he specializes in developing advanced implantable medical devices that relate to monitoring and enhancing patient care.

Latest Patents

Tcheng's recent patents include groundbreaking systems and methods utilizing phase-amplitude coupling measures in implantable medical devices. One of his notable inventions involves a sensor that detects electrical activity in the brain. The data analyzer within this device processes the brain signals to measure phase-amplitude coupling between oscillations in low and high-frequency ranges. For instance, it can differentiate between theta frequency oscillations and gamma frequency oscillations, providing crucial insights into brain activity.

Another significant patent focuses on assessing the effectiveness of a therapy involving a drug regimen through implanted medical devices. This innovation allows for real-time feedback and analysis of physiological data. The system can modify treatment parameters based on patient responses to achieve optimal therapeutic effects, integrating both drug regimens and electrical stimulation therapies harmoniously.

Career Highlights

Tcheng has been a vital part of Neuropace, Inc., contributing to its reputation as a leader in innovative neurotechnology. His work has not only advanced the understanding of brain dynamics but has also enhanced therapeutic strategies for patients with neurological disorders.

Collaborations

Thomas K. Tcheng collaborates with esteemed colleagues such as Benjamin D. Pless and Brett M. Wingeier. Together, they are part of a dedicated team committed to transforming the landscape of implantable medical devices, striving to improve patient outcomes through innovative technology.

Conclusion

Through his inventive work at Neuropace, Inc., Thomas K. Tcheng exemplifies the role of an innovator in medical technology. His contributions continue to impact the fields of neurostimulation and patient therapy, showcasing the potential of modern inventions to enhance healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…